NEBIDO 1000MG 4ML SOLUTION FOR INJECTION

The injection interval should always be within the recommended range of 10to 14 weeks. The solution for intramuscular injection is to be visually inspected prior to use and only clear solutions https://copterjet.com.ng/understanding-steroids-an-in-depth-exploration-2/ free from particles should be used. You will not be prescribed Nebido if you have ever had a liver tumour (see “Do not use Nebido”). The solution for intramuscular injection is to be visually inspected prior to use and only clear solutions free from particles should be used. This medicinal product does not require any special storage conditions. Dependent on the target organ, the spectrum of activities of testosterone is mainly androgenic (e.g. prostate, seminal vesicles, epididymis) or protein-anabolic (muscle, bone, haematopoiesis, kidney, liver).

Risks associated with treatment of late-onset hypogonadism

NEBIDO® is discontinued When treatment with NEBIDO® is terminated, symptoms of testosterone deficiency may reappear. Your doctor, especially if you are older, will perform regular prostate examinations, and will regularly take a blood sample from you. Do not use high or low doses other than the recommended dose for the drug. In one study with 14 days of daily use, 42% of patients reported 3 or more detachments of their Nebido 1000mg/4 ml (Nebido 1000mg/4 ml (transdermal)) TTS; of these detachments, 33% occurred during exercise.

Within a few months, Mark noticed a significant improvement in his energy levels, sleep quality, and sex drive. He regained his motivation for exercise, leading to increased muscle mass and weight loss. Mark’s experience highlights how NEBIDO can restore a man’s vitality and improve his overall well-being.

Bone density

• Nebido is not for use in women and must not be used in pregnant or breast-feeding women.
• Nebido has no observed effect on your ability to drive or use machines.
• However, it will be correct to inform your doctor of the situation that does not occur within a short time.
• Nebido should be permanently withdrawn if symptoms of excessive androgen exposure persist or reappear during treatment with the recommended dosage regimen.
• Lead to signs and symptoms such as cough, dyspnoea, malaise, hyperhidrosis, chest pain, dizziness, paraesthesia, or syncope.

Once injected intramuscularly (usually into the buttocks), NEBIDO forms a deposit at the injection site. The testosterone undecanoate slowly breaks down and releases testosterone into the bloodstream through a process called lymphatic absorption. The lymphatic system is a network of vessels that drains fluid from tissues throughout the body, eventually delivering it back to the bloodstream.

The major active metabolites of testosterone are oestradiol and dihydrotestosterone. In serum of men, about 98% of the circulating testosterone is bound to sex hormone binding globulin (SHBG) and albumin. Only the free fraction of testosterone is considered as biologically active. Following intravenous infusion of testosterone to elderly men, the elimination half-life of testosterone was approximately one hour and an apparent volume of distribution of about 1.0 l/kg was determined.

If stored at cold temperature, the product should be brought to room or body temperature before use. After removal of the plastic cap (A) do not remove the metal ring (B) or the crimp cap (C). The medicinal product is for single use only and any unused solution should be discarded in accordance with local requirements. If stored at cold temperature, the product should be brought to room or body temperature before use. In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.